NEW YORK, Sept. 4-The California company DNA Sciences said today that it had struck a pharmacogenomics research collaboration with Germany's Merck Group.
Researchers from the two companies will work together to identify DNA variants associated with different drug responses. The team will then analyze allele frequencies of those genes in three separate ethnic groups.
Merck Group (Merck KGaA) is an international pharmaceutical and chemical manufacturer based in Darmstadt, Germany.
DNA Sciences, based in Fremont, Calif., develops and markets DNA-based diagnostics and pharmacogenomic techniques.